Cargando…
Beinaglutide showed significant weight‐loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real‐world setting: a 3‐month, multicentre, observational, retrospective, open‐label study
AIMS: The purpose of this study was to examine the effectiveness of beinaglutide on body weight, glycated haemoglobin (HbA(1c)), blood pressure and lipid profiles in patients with type 2 diabetes mellitus (T2DM) in a real‐world setting in China. MATERIALS AND METHODS: This was a multicentre, observa...
Autores principales: | Zhang, Y. L., Zhou, C., Li, X. F., Yang, M. N., Tao, L., Zheng, X. Y., Jia, Y. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700512/ https://www.ncbi.nlm.nih.gov/pubmed/31452921 http://dx.doi.org/10.1002/osp4.342 |
Ejemplares similares
-
Comparison of Beinaglutide Versus Metformin for Weight Loss in
Overweight and Obese Non-diabetic Patients
por: Gao, Lijun, et al.
Publicado: (2021) -
Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity
por: Wang, Guiying, et al.
Publicado: (2021) -
Effectiveness of beinaglutide in a patient with late dumping syndrome after gastrectomy: A case report
por: Ding, Bo, et al.
Publicado: (2021) -
Recombinant human GLP-1 beinaglutide regulates lipid metabolism of adipose tissues in diet-induced obese mice
por: Zhang, Feng, et al.
Publicado: (2021) -
Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial
por: Zhou, T., et al.
Publicado: (2021)